TIRmed Pharma AB
  • Home
  • Our Company
  • Research & Development
  • Contact
  • News

Month: May 2020

TIRmed Pharma receives approval of patent in the US

TIRmed Pharma´s proprietary compound to treat inflammatory skin disorders was issued patent approval in the US, April 21st, 2020. 

Posted on: Posted on May 12, 2020

Categories: Uncategorized

TIRmed Pharma receives SME Instrument Phase 1 grant from EU Grant No 885787-TIR-C

In Dec, 2019 TIRmed Pharma was awarded funding from the European Union´s Horizon 2020 research and innovation progamme under grant agreement number 885787-TIR-C regarding the development of a cream to treat immune responses in atopic dermatitis.

Posted on: Posted on May 12, 2020

Categories: Uncategorized

Recent Posts

  • TIRmed Pharma raises 5.4 MSEK in equity to continue pursuing preclinical development of new antiviral treatment and a topical treatment for atopic eczema.
  • New publication
  • TIRmed Pharma receives approval to grant patents in Europe
  • TIRmed Pharma receives approval of patent in the US
  • TIRmed Pharma receives SME Instrument Phase 1 grant from EU Grant No 885787-TIR-C

Archives

  • November 2020
  • October 2020
  • June 2020
  • May 2020
  • September 2018
© 2021 TIRmed Pharma AB, All rights reserved.
  • Our Company
  • Contact
  • News
  • Privacy Policy

TIRmed Pharma AB

P: +46 (0) 70 747 1303
E: [email protected]